Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NETWORK × Bendamustine Hydrochloride × Clear all

Phase

Phase 2 7 Phase 3 1

Status

Sponsor Class

INDUSTRY 43 OTHER 10 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1

Interventions

Radiotherapy 124 Cyclophosphamide 99 Cisplatin 96 Doxorubicin 91 Vincristine 69 Filgrastim 55 Etoposide 53 Paclitaxel 51 Carboplatin 50 Fluorouracil 48 Methotrexate 45 Dexamethasone 43 Prednisone 38 Cytarabine 38 Leucovorin 35 Granulocyte Colony-Stimulating Factor 31 Docetaxel 31 Radiation 27 Ifosfamide 25 Tamoxifen 24 Daunorubicin 23 Calcium Dobesilate 23 Specimen Handling 22 Gemcitabine 21 Platinum 20 Mercaptopurine 20 Magnetic Resonance Spectroscopy 20 Chemotherapy, Adjuvant 20 1,2-diaminocyclohexaneplatinum II citrate 20 Goserelin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02423837 2015-04-22

BRiF

National Research Center for Hematology, Russia

Phase 3 Unknown

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡